ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial

by | Dec 4, 2025 | Clinical Trials | 0 comments

​ Conditions: Mantle Cell Lymphoma (MCL)

Interventions: Drug: ZSDT regimen

Sponsors: Zhengzhou University

Not yet recruiting Conditions: Mantle Cell Lymphoma (MCL)
Interventions: Drug: ZSDT regimen
Sponsors: Zhengzhou University
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *